Cargando…

Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI

OBJECTIVES: To assess the differences between normal and cirrhotic livers by means of T1 mapping of liver parenchyma on gadoxetic acid (Gd-EOB-DTPA)-enhanced 3 Tesla (3T) MR imaging (MRI). METHODS: 162 patients with normal (n = 96) and cirrhotic livers (n = 66; Child-Pugh class A, n = 30; B, n = 28;...

Descripción completa

Detalles Bibliográficos
Autores principales: Haimerl, Michael, Verloh, Niklas, Zeman, Florian, Fellner, Claudia, Müller-Wille, René, Schreyer, Andreas G., Stroszczynski, Christian, Wiggermann, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877368/
https://www.ncbi.nlm.nih.gov/pubmed/24392025
http://dx.doi.org/10.1371/journal.pone.0085658
_version_ 1782297633471070208
author Haimerl, Michael
Verloh, Niklas
Zeman, Florian
Fellner, Claudia
Müller-Wille, René
Schreyer, Andreas G.
Stroszczynski, Christian
Wiggermann, Philipp
author_facet Haimerl, Michael
Verloh, Niklas
Zeman, Florian
Fellner, Claudia
Müller-Wille, René
Schreyer, Andreas G.
Stroszczynski, Christian
Wiggermann, Philipp
author_sort Haimerl, Michael
collection PubMed
description OBJECTIVES: To assess the differences between normal and cirrhotic livers by means of T1 mapping of liver parenchyma on gadoxetic acid (Gd-EOB-DTPA)-enhanced 3 Tesla (3T) MR imaging (MRI). METHODS: 162 patients with normal (n = 96) and cirrhotic livers (n = 66; Child-Pugh class A, n = 30; B, n = 28; C, n = 8) underwent Gd-EOB-DTPA-enhanced 3T MRI. To obtain T1 maps, two TurboFLASH sequences (TI = 400 ms and 1000 ms) before and 20 min after Gd-EOB-DTPA administration were acquired. T1 relaxation times of the liver and the reduction rate between pre- and post-contrast enhancement images were measured. RESULTS: The T1 relaxation times for Gd-EOB-DTPA-enhanced MRI showed significant differences between patients with normal liver function and patients with Child-Pugh class A, B, and C (p < 0.001). The T1 relaxation times showed a constant significant increase from Child-Pugh class A up to class C (Child-Pugh class A, 335 ms ± 80 ms; B, 431 ms ± 75 ms; C, 557 ms ± 99 ms; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001) and a constant decrease of the reduction rate of T1 relaxation times (Child-Pugh class A, 57.1% ± 8.8%; B, 44.3% ± 10.2%, C, 29.9% ± 6.9%; Child-Pugh A to B, p < 0.001; Child-Pugh A to C,p < 0.001; Child-Pugh B to C, p < 0.001). CONCLUSION: Gd-EOB-DTPA-enhanced T1 mapping of the liver parenchyma may present a useful method for determining severity of liver cirrhosis.
format Online
Article
Text
id pubmed-3877368
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38773682014-01-03 Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI Haimerl, Michael Verloh, Niklas Zeman, Florian Fellner, Claudia Müller-Wille, René Schreyer, Andreas G. Stroszczynski, Christian Wiggermann, Philipp PLoS One Research Article OBJECTIVES: To assess the differences between normal and cirrhotic livers by means of T1 mapping of liver parenchyma on gadoxetic acid (Gd-EOB-DTPA)-enhanced 3 Tesla (3T) MR imaging (MRI). METHODS: 162 patients with normal (n = 96) and cirrhotic livers (n = 66; Child-Pugh class A, n = 30; B, n = 28; C, n = 8) underwent Gd-EOB-DTPA-enhanced 3T MRI. To obtain T1 maps, two TurboFLASH sequences (TI = 400 ms and 1000 ms) before and 20 min after Gd-EOB-DTPA administration were acquired. T1 relaxation times of the liver and the reduction rate between pre- and post-contrast enhancement images were measured. RESULTS: The T1 relaxation times for Gd-EOB-DTPA-enhanced MRI showed significant differences between patients with normal liver function and patients with Child-Pugh class A, B, and C (p < 0.001). The T1 relaxation times showed a constant significant increase from Child-Pugh class A up to class C (Child-Pugh class A, 335 ms ± 80 ms; B, 431 ms ± 75 ms; C, 557 ms ± 99 ms; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001) and a constant decrease of the reduction rate of T1 relaxation times (Child-Pugh class A, 57.1% ± 8.8%; B, 44.3% ± 10.2%, C, 29.9% ± 6.9%; Child-Pugh A to B, p < 0.001; Child-Pugh A to C,p < 0.001; Child-Pugh B to C, p < 0.001). CONCLUSION: Gd-EOB-DTPA-enhanced T1 mapping of the liver parenchyma may present a useful method for determining severity of liver cirrhosis. Public Library of Science 2013-12-31 /pmc/articles/PMC3877368/ /pubmed/24392025 http://dx.doi.org/10.1371/journal.pone.0085658 Text en © 2013 Haimerl et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Haimerl, Michael
Verloh, Niklas
Zeman, Florian
Fellner, Claudia
Müller-Wille, René
Schreyer, Andreas G.
Stroszczynski, Christian
Wiggermann, Philipp
Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title_full Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title_fullStr Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title_full_unstemmed Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title_short Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
title_sort assessment of clinical signs of liver cirrhosis using t1 mapping on gd-eob-dtpa-enhanced 3t mri
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877368/
https://www.ncbi.nlm.nih.gov/pubmed/24392025
http://dx.doi.org/10.1371/journal.pone.0085658
work_keys_str_mv AT haimerlmichael assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT verlohniklas assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT zemanflorian assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT fellnerclaudia assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT mullerwillerene assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT schreyerandreasg assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT stroszczynskichristian assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri
AT wiggermannphilipp assessmentofclinicalsignsoflivercirrhosisusingt1mappingongdeobdtpaenhanced3tmri